Published in Rev Esp Cardiol on April 01, 2005
Validation of the GRACE risk score for predicting death within 6 months of follow-up in a contemporary cohort of patients with acute coronary syndrome. Rev Esp Cardiol (2010) 2.78
[Clinical features and prognosis of patients with chronic cerebrovascular disease (ICBAR study)]. Rev Neurol (2011) 2.57
[Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery]. Rev Esp Cardiol (2006) 2.26
Cardiac troponin I and creatine kinase MB isoenzyme in patients with chronic renal failure. Nefrologia (2012) 1.96
Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. Cardiovasc Res (2004) 1.60
Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett (2005) 1.58
[Evolution and scientific impact of research grants from the spanish society of cardiology and spanish heart foundation (2000-2006)]. Rev Esp Cardiol (2011) 1.45
Impact of new criteria for anticoagulant treatment in atrial fibrillation. Rev Esp Cardiol (2011) 1.44
[Renal failure is an independent predictor of mortality in hospitalized heart failure patients and is associated with a worse cardiovascular risk profile]. Rev Esp Cardiol (2006) 1.42
Prevalence of chronic kidney disease in patients with or at a high risk of cardiovascular disease. Rev Esp Cardiol (2010) 1.41
Influence of the preimplantation QRS axis on responses to cardiac resynchronization therapy. Rev Esp Cardiol (2008) 1.40
[Pneumopericardium complicating bronchogenic carcinoma]. Rev Esp Cardiol (2002) 1.06
[Diabetes mellitus in cardiology practice in Spain. Survey by the Working Group on Heart and Diabetes regarding the importance of diabetes mellitus in relation with other cardiovascular diseases]. Rev Esp Cardiol (2004) 1.00
Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels: New Roles for Soluble RAGE. Eur J Heart Fail (2010) 0.99
Glycated albumin, a precursor of advanced glycation end-products, up-regulates NADPH oxidase and enhances oxidative stress in human endothelial cells: molecular correlate of diabetic vasculopathy. Diabetes Metab Res Rev (2010) 0.96
Pravastatin counteracts angiotensin II-induced upregulation and activation of NADPH oxidase at plasma membrane of human endothelial cells. J Cardiovasc Pharmacol (2010) 0.93
[Gender differences in adiponectin and leptin expression in epicardial and subcutaneous adipose tissue. Findings in patients undergoing cardiac surgery]. Rev Esp Cardiol (2006) 0.89
Coronary artery disease is associated with higher epicardial retinol-binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue. Clin Endocrinol (Oxf) (2012) 0.89
Influence of diabetes on the survival of patients hospitalized with heart failure: a 12-year study. Eur J Heart Fail (2005) 0.89
Des-acyl ghrelin has specific binding sites and different metabolic effects from ghrelin in cardiomyocytes. Endocrinology (2010) 0.88
Morbidity and mortality among heart failure patients in Galicia, N.W. Spain: the GALICAP Study. Int J Cardiol (2008) 0.88
Left ventricular mass regression after aortic valve replacement with the new Mitroflow 12A pericardial bioprosthesis. J Heart Valve Dis (2006) 0.86
Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report. Cardiovasc Diabetol (2012) 0.85
Current status of NADPH oxidase research in cardiovascular pharmacology. Vasc Health Risk Manag (2013) 0.85
Leptin does not induce hypertrophy, cell cycle alterations, or production of MCP-1 in cultured rat and mouse cardiomyocytes. Endocr Res (2005) 0.84
[Comparison of coronary risk estimates derived using the Framingham and REGICOR equations]. Rev Esp Cardiol (2005) 0.83
Adiponectin and p53 mRNA in epicardial and subcutaneous fat from heart failure patients. Eur J Clin Invest (2013) 0.82
Evidence for a role of advanced glycation end products in atrial fibrillation. Int J Cardiol (2011) 0.82
[Influence of sex on mortality in hospitalized patients with congestive heart failure and preserved or depressed systolic function]. Rev Esp Cardiol (2005) 0.81
[Factors associated with uncontrolled hypertension in patients with and without cardiovascular disease]. Rev Esp Cardiol (2011) 0.81
Influence of heart failure on nucleolar organization and protein expression in human hearts. Biochem Biophys Res Commun (2012) 0.81
Infective endocarditis due to Streptococcus bovis in a series of nonaddict patients: clinical and morphological characteristics of 20 cases and review of the literature. Can J Cardiol (2003) 0.81
Procyanidins from grape pomace are suitable inhibitors of human endothelial NADPH oxidase. J Cell Biochem (2012) 0.80
Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of Seattle Heart Failure Score. Am J Cardiol (2011) 0.80
Diagnostic value of N-terminal pro-brain natriuretic peptide in pleural effusions of cardiac origin. Arch Bronconeumol (2011) 0.79
Evaluation of a multiplex real-time PCR assay for detecting pathogens in cardiac valve tissue in patients with endocarditis. Rev Esp Cardiol (2010) 0.79
Trends in clinical profile and medical treatments of atrial fibrillation patients over the last 10 years. Rev Port Cardiol (2013) 0.79
Percutaneous coronary intervention in a patient with a CoreValve aortic valve prosthesis. Rev Esp Cardiol (2010) 0.78
Fluorescent advanced glycation end products and their soluble receptor: the birth of new plasmatic biomarkers for risk stratification of acute coronary syndrome. PLoS One (2013) 0.78
[Global treatment of cardiovascular risk in the hypertensive patient]. Rev Esp Cardiol (2007) 0.77
Statins modulate feedback regulation mechanisms between advanced glycation end-products and C-reactive protein: evidence in patients with acute myocardial infarction. Eur J Pharm Sci (2013) 0.77
Short-term metabolic changes achieved by weight loss in hypertensive patients. Int J Cardiol (2010) 0.76
Effect of diabetes on the clinical characteristics and prognosis of patients with chronic ischemic heart disease. The CIBAR study. Rev Esp Cardiol (2010) 0.76
[Dyslipemia in diabetics treated with statins. Results of the DYSIS study in Spian]. Med Clin (Barc) (2012) 0.76
Cystatin C provides more information than other renal function parameters for stratifying risk in patients with acute coronary syndrome. Rev Esp Cardiol (2009) 0.76
Sex does not influence prognosis in diabetic patients. The Barbanza Diabetes study. Rev Esp Cardiol (2010) 0.76
Diagnostic accuracy of computer-assisted electrocardiography in the diagnosis of left ventricular hypertrophy in left bundle branch block. Rev Esp Cardiol (Engl Ed) (2011) 0.76
[Ankle brachial index and cardiovascular risk]. Med Clin (Barc) (2003) 0.76
Assessment of long-term quality of life after cavotricuspid isthmus ablation for typical atrial flutter. Health Qual Life Outcomes (2014) 0.75
Response to the comment on "Cardiac troponin I and creatine kinase MB isoenzyme in patients with chronic renal failure". Nefrologia (2013) 0.75
Importance of recognizing occult renal disease in hypertensive patients. Rev Esp Cardiol (2009) 0.75
[Beyond blood pressure reduction in the treatment of arterial hypertension. Clinical implications of the LIFE study]. Rev Esp Cardiol (2002) 0.75
Comments on the 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. Rev Esp Cardiol (Engl Ed) (2016) 0.75
Left bundle branch block in atrial fibrillation patients without heart failure. Int J Cardiol (2013) 0.75
[Ignoring familiar decision for increasing organ donations?]. Med Clin (Barc) (2006) 0.75
[Changes in lipid profile after regular intake of canned fish. The influence of addition of isoflavones, omega-3 fatty acids and fitosterols]. Med Clin (Barc) (2007) 0.75
[Impact of concomitant use of P2Y12 inhibitors and proton pump inhibitors on ischemia events in patients with acute coronary syndrome in real world]. Zhonghua Yi Xue Za Zhi (2016) 0.75
[Hypertensive heart disease: a proposed clinical classification]. Rev Esp Cardiol (2006) 0.75
[Aldosterone blockade in heart failure. So much for so little]. Med Clin (Barc) (2002) 0.75
[Blood pressure control in hypertensive patients with left ventricular hypertrophy. The VIIDA Study]. Rev Esp Cardiol (2007) 0.75
[Cardiovascular disease and hypertensive cardiomyopathy. Beyond heart]. Med Clin (Barc) (2006) 0.75
Advanced glycation end-products as long-term predictors of death and reinfarction after an acute coronary syndrome. Biomark Med (2015) 0.75
Prognostic impact of atrial fibrillation progression in a community study: AFBAR Study (Atrial Fibrillation in the Barbanza Area Study). Int J Cardiol (2010) 0.75
[Not Available]. Rev Esp Cardiol (2010) 0.75
[Advanced glycation end-products: new markers of renal dysfunction in patients with chronic heart failure]. Med Clin (Barc) (2011) 0.75
Structural and functional inverse cardiac remodeling after cavotricuspid isthmus ablation in patients with typical atrial flutter. Rev Esp Cardiol (Engl Ed) (2012) 0.75
[Galician study of heart failure in primary care (GALICAP Study)]. Rev Esp Cardiol (2007) 0.75
Heart failure with recovered ejection fraction: clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry. Cardiol J (2017) 0.75